Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Glennon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the American Heart Association|July 29, 2021
Replication Stress Response Modifies Sarcomeric Cardiomyopathy RemodelingSoumojit Pal, Benjamin R Nixon, Michael S Glennon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 15, 2018
Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage responseBenjamin R Nixon, Sara C Sebag, Michael S Glennon, et al.
JCI Insight|February 28, 2017
Alterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte developmentBenjamin R Nixon, Alexandra F Williams, Michael S Glennon, et al.
Cardiovascular Research|January 11, 2019
Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategiesAnand P Singh, Michael S Glennon, Prachi Umbarkar, et al.
Cardiovascular Research|July 30, 2021
Cardiac natriuretic peptide deficiency sensitizes the heart to stress-induced ventricular arrhythmias via impaired CREB signallingEric J Hall, Soumojit Pal, Michael S Glennon, et al.
BMC Microbiology|September 16, 2018
Pseudomonas aeruginosa responds to exogenous polyunsaturated fatty acids (PUFAs) by modifying phospholipid composition, membrane permeability, and phenotypes associated with virulenceLyssa Y Baker, Chelsea R Hobby, Andrew W Siv, et al.
Circulation|October 27, 2023
MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic CardiomyopathyPuneeth Shridhar, Michael S Glennon, Soumojit Pal, et al.
Circulation Research|September 15, 2025
Targeting Cardiomyocyte PCNA and POLD1 Prevents Pathologic Myocardial HypertrophySoumojit Pal, Michael S Glennon, Benjamin R Nixon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the American Heart Association|July 29, 2021
Replication Stress Response Modifies Sarcomeric Cardiomyopathy RemodelingSoumojit Pal, Benjamin R Nixon, Michael S Glennon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 15, 2018
Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage responseBenjamin R Nixon, Sara C Sebag, Michael S Glennon, et al.
JCI Insight|February 28, 2017
Alterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte developmentBenjamin R Nixon, Alexandra F Williams, Michael S Glennon, et al.
Cardiovascular Research|January 11, 2019
Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategiesAnand P Singh, Michael S Glennon, Prachi Umbarkar, et al.
Cardiovascular Research|July 30, 2021
Cardiac natriuretic peptide deficiency sensitizes the heart to stress-induced ventricular arrhythmias via impaired CREB signallingEric J Hall, Soumojit Pal, Michael S Glennon, et al.
BMC Microbiology|September 16, 2018
Pseudomonas aeruginosa responds to exogenous polyunsaturated fatty acids (PUFAs) by modifying phospholipid composition, membrane permeability, and phenotypes associated with virulenceLyssa Y Baker, Chelsea R Hobby, Andrew W Siv, et al.
Circulation|October 27, 2023
MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic CardiomyopathyPuneeth Shridhar, Michael S Glennon, Soumojit Pal, et al.
Circulation Research|September 15, 2025
Targeting Cardiomyocyte PCNA and POLD1 Prevents Pathologic Myocardial HypertrophySoumojit Pal, Michael S Glennon, Benjamin R Nixon, et al.
Pageof 1